CNS Pharmaceuticals to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sep 17, 2020 8:00am EDT
CNS Pharmaceuticals to Present at the H.C. Wainwright & Co. 22nd Annual Global Investment Conference Sep 11, 2020 8:00am EDT
CNS Pharmaceuticals Announces Appointment of Dr. Patrick Wen, Director of Center for Neuro-Oncology at Dana-Farber Cancer Institute, to Science Advisory Board Aug 27, 2020 8:00am EDT
CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020 Aug 11, 2020 8:00am EDT
CNS Pharmaceuticals Completes Drug Product Manufacturing Strategy for Berubicin Jul 15, 2020 8:00am EDT
